$7.27
0.476.91%
Last update: Nov 6, 4:42 PM
Kura Oncology Inc
KURANASDAQ
The average analyst price target for Kura Oncology is $24.50, 237.0% above the current price. Of 17 analysts, 14 rate it Buy and 3 Hold. Targets range from $10 to $40. The latest change came on Oct 1, 2026, when JP Morgan initiated coverage of Kura Oncology with an Overweight rating and a $30 price target.
Price Target Range — 13 Quarters
Analyst Consensus — 17 Analysts
Rating Trend — Last 9 Months
